Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis
Clinical trial NCT02493335 · COMPLETED
Trial details
- NCT number
- NCT02493335
- Sponsor
- Dr. Falk Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-15
- Primary completion
- 2018-11-28
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.